VAIOMER
  • VAIOMER
    • About VAIOMER
    • Contamination-aware approach
    • Microbiome discovery timeline
    • Microbiome analysis services
    • News
  • ABOUT MICROBIOME
    • Definitions
    • Translational research
    • Bacterial translocation
    • Atlas of microbiomes
  • MICROBIOME APPLICATIONS
    • Skin microbiome
    • Cardio-metabolic diseases
    • Liver diseases
    • Gastrointestinal disorders
    • Cancer
    • Neurodegenerative and mental disorders
    • COVID & Infectious diseases
    • Autoimmune and inflammatory diseases
    • Nutrition
    • Kidney diseases
    • Microbiome in early life
  • RESOURCES
  • CONTACT
  • #
  • #
Select Page
Metabolism and Obesity: Oral microbiota and fat taste sensitivity

Metabolism and Obesity: Oral microbiota and fat taste sensitivity

by microbiome | Apr 5, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

doi: 10.3389/fnut.2022.1046454 The relationship between oral microbiome and fat taste sensitivity in obese patients after sleeve gastrectomy Bernard et al. explored the relationship between oral microbiota composition & fat taste sensitivity in obese patients...
Metabolism and T2D: GLP-1 sensitivity is linked with clock genes and ileal microbiome

Metabolism and T2D: GLP-1 sensitivity is linked with clock genes and ileal microbiome

by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-021-01790-y Association between the gut-brain-beta cell glucagon-like peptide-1(GLP-1)-dependent axis, the gut microbiota and the insulin sensitivity Grasset et al. explored the association between the gut-brain-beta cell glucagon-like peptide-1...
Metabolism and T2D: liraglutide influences glucose metabolism and inflammation through gut microbiota

Metabolism and T2D: liraglutide influences glucose metabolism and inflammation through gut microbiota

by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-020-01657-8 Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate insulin secretion Charpentier and colleagues showed that Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate insulin...
Metabolism and Glycemic control: the crosstalk between intestinal microbiota and immune system

Metabolism and Glycemic control: the crosstalk between intestinal microbiota and immune system

by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1007/s00592-021-01682-1 The tight crosstalk between the intestinal immune system and the microbiota in glucose intolerance  In this article, Pomié et al. study the importance of the tight crosstalk between the intestinal immune system and the microbiota in...
Metabolism and endurance training: contribution of blood and muscle microbiomes

Metabolism and endurance training: contribution of blood and muscle microbiomes

by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.3390/biomedicines10010064 Identification of tissue-specific variations of the microbiome resulting from endurance training Villarroel and colleagues (2022) explored the contribution of tissue microbiome on muscle function in Endurance Training: → The authors...
« Older Entries
Next Entries »

Research

Categorie

  • Highlights (32)
  • Microbiomes & cancer (5)
  • Microbiomes & Metabolism (9)
  • News (15)
  • Skin Microbiome (1)
  • Vaiomer original work (17)

Archives

  • Cross-Influence of Tick and Host Skin Microbiomes During Tick Bites: A New Frontier in Understanding Pathogen Transmission
  • Vaiomer will be attending «Journées Polepharma de Microbiomique, 4ème édition»
  • Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»
  • Vaiomer is participating in the Genotoul Scientific Day-HOLOBIONTES
  • Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release

516, rue Pierre et Marie Curie
31670 Labège, France
Tel : +33 (0)5 61 28 71 66
Fax : +33 (0)5 61 28 71 68
Contact us !

 

About Vaiomer :

Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases.

 

Follow us !

Vaiomer ©  – Legal Notice and Privacy Policy and GDPR conditions– Conception by Comm’IN

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.